SymBio Pharmaceuticals Balance Sheet

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	1,898	2,883	3,963	6,517	6,282	3,860
Cash & Short-Term Investments	1,898	2,883	3,963	6,517	6,282	3,860
Cash Growth	-47.49%	-27.25%	-39.19%	3.74%	62.74%	0.30%
Accounts Receivable	192.99	259	423	913	2,084	2,148
Receivables	192.99	259	423	913	2,084	2,148
Inventory	183.15	288	238	232	469	385.68
Prepaid Expenses	284.55	60	110	119	209	145.01
Other Current Assets	348.96	334	190	301	268	209.53
Total Current Assets	2,908	3,824	4,924	8,082	9,312	6,748
Property, Plant & Equipment	-	-	-	-	69	83.64
Long-Term Investments	0.02	38	44	87	85	-
Other Intangible Assets	-	-	-	-	222	259.1
Long-Term Deferred Tax Assets	1.98	5	-	-	744	1,276
Other Long-Term Assets	37.35	-	-	1	1	86.66
Total Assets	2,947	3,867	4,968	8,170	10,433	8,453
Accounts Payable	1,478	-	-	-	46	69.68
Accrued Expenses	-	-	-	-	-	516.04
Current Portion of Long-Term Debt	927.5	682	-	-	-	-
Current Income Taxes Payable	69.04	586	737	872	1,564	383.6
Other Current Liabilities	136.24	22	29	84	313	548.79
Total Current Liabilities	2,610	1,290	766	956	1,923	1,518
Long-Term Debt	100	1,300	-	-	-	-
Pension & Post-Retirement Benefits	4.91	4	4	3	3	2.78
Other Long-Term Liabilities	0	3	3	1	2	186.44
Total Liabilities	2,715	2,597	773	960	1,928	1,707
Common Stock	19,953	19,244	18,336	17,952	17,548	17,158
Additional Paid-In Capital	19,928	19,218	18,311	17,927	17,523	17,133
Retained Earnings	-39,863	-37,461	-32,685	-28,852	-26,889	-27,978
Treasury Stock	-89.87	-89	-89	-89	-88	-86.05
Comprehensive Income & Other	304.33	358	322	272	411	519.1
Shareholders' Equity	231.69	1,270	4,195	7,210	8,505	6,746
Total Liabilities & Equity	2,947	3,867	4,968	8,170	10,433	8,453
Total Debt	1,028	1,982	-	-	-	-
Net Cash (Debt)	870.42	901	3,963	6,517	6,282	3,860
Net Cash Growth	-70.14%	-77.27%	-39.19%	3.74%	62.74%	0.30%
Net Cash Per Share	15.79	17.94	87.88	163.32	158.62	99.38
Filing Date Shares Outstanding	72.15	71.78	47.83	44.75	39.52	38.37
Total Common Shares Outstanding	72.15	59.48	45.84	42.19	39.52	38.37
Working Capital	297.26	2,534	4,158	7,126	7,389	5,230
Book Value Per Share	3.21	21.35	91.52	170.89	215.22	175.78
Tangible Book Value	231.69	1,270	4,195	7,210	8,283	6,487
Tangible Book Value Per Share	3.21	21.35	91.52	170.89	209.60	169.03
Buildings	-	-	-	-	-	64.62
Machinery	-	-	-	-	-	72.73